Epigenetic deregulation in pediatric acute lymphoblastic leukemia

Epigenetics

Volumn 9, Issue 3, 2014, Pages 459-467

  Chatterton, Zac ^a   Morenos, Leah ^a   Mechinaud, Francoise ^b   Ashley, David M ^c   Craig, Jeffrey M ^a   Sexton Oates, Alexandra ^a   Halemba, Minhee S ^a   Parkinson Bates, Mandy ^a   Ng, Jane ^a   Morrison, Debra ^d   Carroll, William L ^d   Saffery, Richard ^a   Wong, Nicholas C ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c DEAKIN UNIVERSITY   (Australia)

^d NEW YORK UNIVERSITY   (United States)

Author keywords

Acute lymphoblastic leukemia; ALL; B cell; DNA methylation; Epigenetics; Hematology; Leukemia

Indexed keywords

CATION CHANNEL; CHEMOKINE RECEPTOR; CXC RECEPTOR 2; CXCL1 CHEMOKINE; CXCL3 CHEMOKINE; CYCLIC AMP; EPHRIN RECEPTOR A5; EPIDERMAL GROWTH FACTOR RECEPTOR 4; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; FIBROBLAST GROWTH FACTOR RECEPTOR 2; GRANULOCYTE CHEMOTACTIC PROTEIN 2; HEAT SHOCK PROTEIN 22; INTERLEUKIN 7; LYMPHOTOXIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 15; MYOSIN III; MYOSIN III A; P21 ACTIVATED KINASE 7; PHOSPHOPROTEIN PHOSPHATASE 2; PROTEIN KINASE; PROTEIN KINASE D1; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE TYPE G; SECRETED FRIZZLED RELATED PROTEIN 1; TRANSCRIPTION FACTOR GATA 4; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN RECEPTOR 2; WNT5B PROTEIN; ZINC FINGER PROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; B CELL LYMPHOMA; BONE MARROW BIOPSY; CONTROLLED STUDY; CPG ISLAND; DIPLOIDY; DNA METHYLATION; DNA MICROARRAY; DOWN REGULATION; EPIGENETICS; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENE TRANSLOCATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERDIPLOID; INTRACELLULAR SIGNALING; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRE B LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALL; B-CELL; DNA METHYLATION; EPIGENETICS; HEMATOLOGY; LEUKEMIA;

CASE-CONTROL STUDIES; CHILD; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; HUMANS; MALE; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 84899141186     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.27585     Document Type: Article

References (64)

1. Bird AP. CpG-rich islands and the function of DNA methylation. Nature 1986; 321:209-13; PMID:2423876; http://dx.doi. org/10.1038/321209a0
2. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev 2002; 16:6-21; PMID:11782440; http://dx.doi.org/10.1101/ gad.947102
3. Mathers JC. Session 2: Personalised nutrition. Epigenomics: a basis for understanding individual differences? Proc Nutr Soc 2008; 67:390-4; PMID:18847515; http://dx.doi.org/10.1017/ S0029665108008744
4. Fang F, Turcan S, Rimner A, Kaufman A, Giri D, Morris LG, Shen R, Seshan V, Mo Q, Heguy A, et al. Breast cancer methylomes establish an epigenomic foundation for metastasis. Sci Transl Med 2011; 3:75ra25; PMID:21430268; http://dx.doi. org/10.1126/scitranslmed.3001875
5. Noushmehr H, Weisenberger DJ, Diefes K, Phillips HS, Pujara K, Berman BP, Pan F, Pelloski CE, Sulman EP, Bhat KP, et al.; Cancer Genome Atlas Research Network. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 2010; 17:510-22; PMID:20399149; http://dx.doi.org/10.1016/j.ccr.2010.03.017
6. Teodoridis JM, Hardie C, Brown R. CpG island methylator phenotype (CIMP) in cancer: causes and implications. Cancer Lett 2008; 268:177-86; PMID:18471961; http://dx.doi.org/10.1016/j. canlet.2008.03.022
7. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 1999; 96:8681-6; PMID:10411935; http://dx.doi. org/10.1073/pnas.96.15.8681
8. Leone G, Teofili L, Voso MT, Lübbert M. DNA methylation and demethylating drugs in myelodysplastic syndromes and secondary leukemias. Haematologica 2002; 87:1324-41; PMID:12495905
9. Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003; 349:2042-54; PMID:14627790; http:// dx.doi.org/10.1056/NEJMra023075
10. Cancer Genome Atlas N; Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature 2012; 490:61-70; PMID:23000897; http://dx.doi.org/10.1038/ nature11412
11. Hinoue T, Weisenberger DJ, Lange CP, Shen H, Byun HM, Van Den Berg D, Malik S, Pan F, Noushmehr H, van Dijk CM, et al. Genome-scale analysis of aberrant DNA methylation in colorectal cancer. Genome Res 2012; 22:271-82; PMID:21659424; http:// dx.doi.org/10.1101/gr.117523.110
12. Deneberg S, Guardiola P, Lennartsson A, Qu Y, Gaidzik V, Blanchet O, Karimi M, Bengtzén S, Nahi H, Uggla B, et al. Prognostic DNA methylation patterns in cytogenetically normal acute myeloid leukemia are predefined by stem cell chromatin marks. Blood 2011; 118:5573-82; PMID:21960591; http:// dx.doi.org/10.1182/blood-2011-01-332353
13. Baylin SB. Resistance, epigenetics and the cancer ecosystem. Nat Med 2011; 17:288-9; PMID:21383739; http://dx.doi.org/10.1038/nm0311-288
14. Esteller M, Garcia-Foncillas J, Andion E, Goodman SN, Hidalgo OF, Vanaclocha V, Baylin SB, Herman JG. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 2000; 343:1350-4; PMID:11070098; http://dx.doi.org/10.1056/NEJM200011093431901
15. Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 2005; 352:997-1003; PMID:15758010; http://dx.doi.org/10.1056/NEJMoa043331
16. Figueroa ME, Abdel-Wahab O, Lu C, Ward PS, Patel J, Shih A, Li Y, Bhagwat N, Vasanthakumar A, Fernandez HF, et al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell 2010; 18:553-67; PMID:21130701; http://dx.doi.org/10.1016/j. ccr.2010.11.015
17. Schuebel KE, Chen W, Cope L, Glöckner SC, Suzuki H, Yi JM, Chan TA, Van Neste L, Van Criekinge W, van den Bosch S, et al. Comparing the DNA hypermethylome with gene mutations in human colorectal cancer. PLoS Genet 2007; 3:1709-23; PMID:17892325; http://dx.doi.org/10.1371/journal. pgen.0030157
18. Christman JK. 5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy. Oncogene 2002; 21:5483-95; PMID:12154409; http://dx.doi.org/10.1038/ sj.onc.1205699
19. Jones PA, Taylor SM. Cellular differentiation, cytidine analogs and DNA methylation. Cell 1980; 20:85-93; PMID:6156004; http://dx.doi. org/10.1016/0092-8674(80)90237-8
20. Wong NC, Ashley D, Chatterton Z, Parkinson-Bates M, Ng HK, Halemba MS, Kowalczyk A, Bedo J, Wang Q, Bell K, et al. A distinct DNA methylation signature defines pediatric pre-B cell acute lymphoblastic leukemia. Epigenetics 2012; 7:535-41; PMID:22531296; http://dx.doi.org/10.4161/ epi.20193
21. Davidsson J, Lilljebjörn H, Andersson A, Veerla S, Heldrup J, Behrendtz M, Fioretos T, Johansson B. The DNA methylome of pediatric acute lymphoblastic leukemia. Hum Mol Genet 2009; 18:4054-65; PMID:19679565; http://dx.doi.org/10.1093/hmg/ ddp354
22. Figueroa ME, Chen SC, Andersson AK, Phillips LA, Li Y, Sotzen J, Kundu M, Downing JR, Melnick A, Mullighan CG. Integrated genetic and epigenetic analysis of childhood acute lymphoblastic leukemia. J Clin Invest 2013; 123:3099-111; PMID:23921123; http://dx.doi.org/10.1172/JCI66203
23. Nordlund J, Bäcklin CL, Wahlberg P, Busche S, Berglund EC, Eloranta ML, Flaegstad T, Forestier E, Frost BM, Harila-Saari A, et al. Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemia. Genome Biol 2013; 14:r105; PMID:24063430; http://dx.doi. org/10.1186/gb-2013-14-9-r105
24. Sproul D, Kitchen RR, Nestor CE, Dixon JM, Sims AH, Harrison DJ, Ramsahoye BH, Meehan RR. Tissue of origin determines cancer-associated CpG island promoter hypermethylation patterns. Genome Biol 2012; 13:R84; PMID:23034185; http://dx.doi. org/10.1186/gb-2012-13-10-r84
25. Hogan LE, Meyer JA, Yang J, Wang J, Wong N, Yang W, Condos G, Hunger SP, Raetz E, Saffery R, et al. Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies. Blood 2011; 118:5218-26; PMID:21921043; http://dx.doi.org/10.1182/ blood-2011-04-345595
26. Myklebust JH, Josefsen D, Blomhoff HK, Levy FO, Naderi S, Reed JC, Smeland EB. Activation of the cAMP signaling pathway increases apoptosis in human B-precursor cells and is associated with downregulation of Mcl-1 expression. J Cell Physiol 1999; 180:71-80; PMID:10362019; http://dx.doi.org/10.1002/ (SICI)1097-4652 (199907)180:1<71::AIDJCP8> 3.0.CO;2-N
27. Naderi EH, Ugland HK, Diep PP, Josefsen D, Ruud E, Naderi S, Blomhoff HK. Selective inhibition of cell death in malignant vs normal B-cell precursors: implications for cAMP in development and treatment of BCP-ALL. Blood 2013; 121:1805-13; PMID:23299313; http://dx.doi.org/10.1182/ blood-2012-08-452698
28. Neves SR, Ram PT, Iyengar R. G protein pathways. Science 2002; 296:1636-9; PMID:12040175; http:// dx.doi.org/10.1126/science.1071550
29. Renna M, Jimenez-Sanchez M, Sarkar S, Rubinsztein DC. Chemical inducers of autophagy that enhance the clearance of mutant proteins in neurodegenerative diseases. J Biol Chem 2010; 285:11061-7; PMID:20147746; http://dx.doi.org/10.1074/jbc. R109.072181
30. Pedersen SF, Stock C. Ion channels and transporters in cancer: pathophysiology, regulation, and clinical potential. Cancer Res 2013; 73:1658-61; PMID:23302229; http://dx.doi.org/10.1158/0008-5472.CAN-12-4188
31. Mattson MP, Chan SL. Calcium orchestrates apoptosis. Nat Cell Biol 2003; 5:1041-3; PMID:14647298; http://dx.doi.org/10.1038/ncb1203-1041
32. Bortner CD, Cidlowski JA. Cell shrinkage and monovalent cation fluxes: role in apoptosis. Arch Biochem Biophys 2007; 462:176-88; PMID:17321483; http:// dx.doi.org/10.1016/j.abb.2007.01.020
33. García-Cao I, Duran A, Collado M, Carrascosa MJ, Martín-Caballero J, Flores JM, Diaz-Meco MT, Moscat J, Serrano M. Tumour-suppression activity of the proapoptotic regulator Par4. EMBO Rep 2005; 6:577-83; PMID:15877079; http://dx.doi. org/10.1038/sj.embor.7400421
34. Das PM, Thor AD, Edgerton SM, Barry SK, Chen DF, Jones FE. Reactivation of epigenetically silenced HER4/ERBB4 results in apoptosis of breast tumor cells. Oncogene 2010; 29:5214-9; PMID:20603612; http://dx.doi.org/10.1038/onc.2010.271
35. Tsatsanis C, Spandidos DA. The role of oncogenic kinases in human cancer (Review). [Review]. Int J Mol Med 2000; 5:583-90; PMID:10812005
36. Quentmeier H, Eberth S, Romani J, Weich HA, Zaborski M, Drexler HG. DNA methylation regulates expression of VEGF-R2 (KDR) and VEGF-R3 (FLT4). BMC Cancer 2012; 12:19; PMID:22251800; http://dx.doi.org/10.1186/1471-2407-12-19
37. Kober P, Bujko M, Oledzki J, Tysarowski A, Siedlecki JA. Methyl-CpG binding column-based identification of nine genes hypermethylated in colorectal cancer. Mol Carcinog 2011; 50:846-56; PMID:21438024; http://dx.doi.org/10.1002/ mc.20763
38. Fu DY, Wang ZM, Wang BL, Chen L, Yang WT, Shen ZZ, Huang W, Shao ZM. Frequent epigenetic inactivation of the receptor tyrosine kinase EphA5 by promoter methylation in human breast cancer. Hum Pathol 2010; 41:48-58; PMID:19733895; http:// dx.doi.org/10.1016/j.humpath.2009.06.007
39. Zhang H, Peng C, Hu Y, Li H, Sheng Z, Chen Y, Sullivan C, Cerny J, Hutchinson L, Higgins A, et al. The Blk pathway functions as a tumor suppressor in chronic myeloid leukemia stem cells. Nat Genet 2012; 44:861-71; PMID:22797726; http://dx.doi. org/10.1038/ng.2350
40. Favreau AJ, Cross EL, Sathyanarayana P. miR-199b-5p directly targets PODXL and DDR1 and decreased levels of miR-199b-5p correlate with elevated expressions of PODXL and DDR1 in acute myeloid leukemia. Am J Hematol 2012; 87:442-6; PMID:22374871; http://dx.doi.org/10.1002/ ajh.23129
41. Touw I, Pouwels K, van Agthoven T, van Gurp R, Budel L, Hoogerbrugge H, Delwel R, Goodwin R, Namen A, Löwenberg B. Interleukin-7 is a growth factor of precursor B and T acute lymphoblastic leukemia. Blood 1990; 75:2097-101; PMID:2189505
42. Silva A, Laranjeira AB, Martins LR, Cardoso BA, Demengeot J, Yunes JA, Seddon B, Barata JT. IL-7 contributes to the progression of human T-cell acute lymphoblastic leukemias. Cancer Res 2011; 71:4780-9; PMID:21593192; http://dx.doi. org/10.1158/0008-5472.CAN-10-3606
43. Puel A, Ziegler SF, Buckley RH, Leonard WJ. Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency. Nat Genet 1998; 20:394-7; PMID:9843216; http://dx.doi. org/10.1038/3877
44. Busche S, Ge B, Vidal R, Spinella JF, Saillour V, Richer C, Healy J, Chen SH, Droit A, Sinnett D, et al. Integration of high-resolution methylome and transcriptome analyses to dissect epigenomic changes in childhood acute lymphoblastic leukemia. Cancer Res 2013; 73:4323-36; PMID:23722552; http:// dx.doi.org/10.1158/0008-5472.CAN-12-4367
45. Milani L, Lundmark A, Kiialainen A, Nordlund J, Flaegstad T, Forestier E, Heyman M, Jonmundsson G, Kanerva J, Schmiegelow K, et al. DNA methylation for subtype classification and prediction of treatment outcome in patients with childhood acute lymphoblastic leukemia. Blood 2010; 115:1214-25; PMID:19965625; http://dx.doi.org/10.1182/ blood-2009-04-214668
46. Nordlund J, Kiialainen A, Karlberg O, Berglund EC, Goransson-Kultima H, Sonderkaer M, Nielsen KL, Gustafsson MG, Behrendtz M, Forestier E, et al. Digital gene expression profiling of primary acute lymphoblastic leukemia cells. Leukemia: official journal of the Leukemia Society of America. Leukemia Research Fund, UK 2012; 26:1218-27; http://dx.doi. org/10.1038/leu.2011.358
47. Zelent A, Greaves M, Enver T. Role of the TELAML1 fusion gene in the molecular pathogenesis of childhood acute lymphoblastic leukaemia. Oncogene 2004; 23:4275-83; PMID:15156184; http://dx.doi. org/10.1038/sj.onc.1207672
48. Pui CH, Carroll WL, Meshinchi S, Arceci RJ. Biology, risk stratification, and therapy of pediatric acute leukemias: an update. J Clin Oncol 2011; 29:551-65; PMID:21220611; http://dx.doi. org/10.1200/JCO.2010.30.7405
49. Torrano V, Procter J, Cardus P, Greaves M, Ford AM. ETV6-RUNX1 promotes survival of early B lineage progenitor cells via a dysregulated erythropoietin receptor. Blood 2011; 118:4910-8; PMID:21900195; http://dx.doi.org/10.1182/blood-2011-05-354266
50. Fine BM, Stanulla M, Schrappe M, Ho M, Viehmann S, Harbott J, Boxer LM. Gene expression patterns associated with recurrent chromosomal translocations in acute lymphoblastic leukemia. Blood 2004; 103:1043-9; PMID:14525776; http://dx.doi. org/10.1182/blood-2003-05-1518
51. Li BS, Gu LJ, Luo CY, Li WS, Jiang LM, Shen SH, Jiang H, Shen SH, Zhang B, Chen J, et al. The downregulation of asparagine synthetase expression can increase the sensitivity of cells resistant to l-asparaginase. Leukemia: official journal of the Leukemia Society of America. Leukemia Research Fund, UK 2006; 20:2199-201; http://dx.doi.org/10.1038/ sj.leu.2404423
52. Ramakers-van Woerden NL, Pieters R, Loonen AH, Hubeek I, van Drunen E, Beverloo HB, Slater RM, Harbott J, Seyfarth J, van Wering ER, et al. TEL/ AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia. Blood 2000; 96:1094-9; PMID:10910927
53. Vrooman LM, Stevenson KE, Supko JG, O'Brien J, Dahlberg SE, Asselin BL, Athale UH, Clavell LA, Kelly KM, Kutok JL, et al. Postinduction dexamethasone and individualized dosing of Escherichia Coli L-asparaginase each improve outcome of children and adolescents with newly diagnosed acute lymphoblastic leukemia: results from a randomized study--Dana-Farber Cancer Institute ALL Consortium Protocol 00-01. J Clin Oncol 2013; 31:1202-10; PMID:23358966; http://dx.doi.org/10.1200/ JCO.2012.43.2070
54. Naor D, Nedvetzki S, Golan I, Melnik L, Faitelson Y. CD44 in cancer. Crit Rev Clin Lab Sci 2002; 39:527-79; PMID:12484499; http://dx.doi. org/10.1080/10408360290795574
55. Yeoh EJ, Ross ME, Shurtleff SA, Williams WK, Patel D, Mahfouz R, Behm FG, Raimondi SC, Relling MV, Patel A, et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 2002; 1:133-43; PMID:12086872; http:// dx.doi.org/10.1016/S1535-6108(02)00032-6
56. Liu J, Jiang G. CD44 and hematologic malignancies. Cell Mol Immunol 2006; 3:359-65; PMID:17092433
57. Paulsson K, Johansson B. High hyperdiploid childhood acute lymphoblastic leukemia. Genes Chromosomes Cancer 2009; 48:637-60; PMID:19415723; http://dx.doi.org/10.1002/ gcc.20671
58. Zheng S, Ma X, Zhang L, Gunn L, Smith MT, Wiemels JL, Leung K, Buffler PA, Wiencke JK. Hypermethylation of the 5′ CpG island of the FHIT gene is associated with hyperdiploid and translocation-negative subtypes of pediatric leukemia. Cancer Res 2004; 64:2000-6; PMID:15026336; http:// dx.doi.org/10.1158/0008-5472.CAN-03-2387
59. Della Peruta M, Martinelli G, Moratti E, Pintani D, Vezzalini M, Mafficini A, Grafone T, Iacobucci I, Soverini S, Murineddu M, et al. Protein tyrosine phosphatase receptor type gamma is a functional tumor suppressor gene specifically downregulated in chronic myeloid leukemia. Cancer Res 2010; 70:8896-906; PMID:20959494; http://dx.doi. org/10.1158/0008-5472.CAN-10-0258
60. Dutta C, Day T, Kopp N, van Bodegom D, Davids MS, Ryan J, Bird L, Kommajosyula N, Weigert O, Yoda A, et al. BCL2 suppresses PARP1 function and nonapoptotic cell death. Cancer Res 2012; 72:4193-203; PMID:22689920; http://dx.doi. org/10.1158/0008-5472.CAN-11-4204
61. Andersson A, Edén P, Olofsson T, Fioretos T. Gene expression signatures in childhood acute leukemias are largely unique and distinct from those of normal tissues and other malignancies. BMC Med Genomics 2010; 3:6; PMID:20211010; http://dx.doi. org/10.1186/1755-8794-3-6
62. Du P, Kibbe WA, Lin SM. lumi: a pipeline for processing Illumina microarray. Bioinformatics 2008; 24:1547-8; PMID:18467348; http://dx.doi. org/10.1093/bioinformatics/btn224
63. Smyth GK. Limma: linear models for microarray data. New York: Springer, 2005.
64. Triche T Jr. IlluminaHumanMethylation450k. db: Illumina Human Methylation 450k annotation data. R package version 1.4.7. Bioconductor; 2012.